Category REGULATORY

Guardant Health Welcomes Pennsylvania Law Expanding No-Cost Access to Innovative Colorectal Cancer Screenings

Guardant Health Applauds Pennsylvania Law Expanding Access to No-Cost Colorectal Cancer Screening Guardant Health, a precision oncology company focused on cancer detection and treatment, has welcomed the enactment of Pennsylvania…

Read MoreGuardant Health Welcomes Pennsylvania Law Expanding No-Cost Access to Innovative Colorectal Cancer Screenings

FDA Approves Guardant360 CDx as Companion Diagnostic for AstraZeneca’s Camizestrant in Advanced Breast Cancer

Guardant Health’s Guardant360 CDx Receives FDA Approval for Camizestrant Companion Diagnostic in Advanced Breast Cancer Guardant Health, a precision oncology company focused on advancing cancer detection and treatment through genomic…

Read MoreFDA Approves Guardant360 CDx as Companion Diagnostic for AstraZeneca’s Camizestrant in Advanced Breast Cancer